Hans C Lee

Hans C Lee

UNVERIFIED PROFILE

Are you Hans C Lee?   Register this Author

Register author
Hans C Lee

Hans C Lee

Publications by authors named "Hans C Lee"

Are you Hans C Lee?   Register this Author

30Publications

727Reads

38Profile Views

A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.

Am J Hematol 2019 Sep 6. Epub 2019 Sep 6.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25633DOI Listing
September 2019

Corrected calcium versus ionized calcium measurements for identifying hypercalcemia in patients with multiple myeloma.

Cancer Treat Res Commun 2019 Sep 5;21:100159. Epub 2019 Sep 5.

Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2019.100159DOI Listing
September 2019

Acute Pancreatitis Associated with Ixazomib in a Multiple Myeloma Patient.

Acta Haematol 2018;139(1):67-70. Epub 2018 Feb 2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000484655DOI Listing
March 2019

Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial.

Lancet Haematol 2018 Dec;5(12):e628-e640

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026183017
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(18)30174-1DOI Listing
December 2018

The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma.

Neoplasia 2017 Oct 30;19(10):772-780. Epub 2017 Aug 30.

Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 511436, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2017.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577403PMC
October 2017

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes.

Oncotarget 2017 Sep 27;8(43):73723-73732. Epub 2017 Aug 27.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650294PMC
September 2017

Advances and practical use of monoclonal antibodies in multiple myeloma therapy.

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):512-520

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142433PMC
December 2016

Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.

Clin Cancer Res 2016 Oct 13;22(19):4901-4912. Epub 2016 Jun 13.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050094PMC
http://dx.doi.org/10.1158/1078-0432.CCR-15-2242DOI Listing
October 2016

Practical Approaches to the Management of Dual Refractory Multiple Myeloma.

Curr Hematol Malig Rep 2016 Apr;11(2):148-55

University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 429, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0312-7DOI Listing
April 2016

Novel approaches to treatment of double-refractory multiple myeloma.

Am Soc Clin Oncol Educ Book 2013

From the Division of Cancer Medicine; Department of Lymphoma/Myeloma; and Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EdBook_AM.2013.33.e302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762449PMC
November 2015

Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for acute myeloid leukemia.

J Natl Compr Canc Netw 2014 Dec;12(12):1660-4; quiz 1664

From the Division of Cancer Medicine, Department of Infectious Disease, and Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0167DOI Listing
December 2014